Improved outcomes following hepatocellular carcinoma (HCC) diagnosis in patients screened for HCC in a large academic liver center versus patients identified in the community

TY - JOUR

T1 - Improved outcomes following hepatocellular carcinoma (HCC) diagnosis in patients screened for HCC in a large academic liver center versus patients identified in the community

AU - Okoronkwo, Nneoma

AU - Wang, Yucai

AU - Pitchumoni, Capecomorin

AU - Koneru, Baburao

AU - Pyrsopoulos, Nikolaos

N1 - Publisher Copyright: © 2017 Authors.

PY - 2017

Y1 - 2017

N2 - Background and Aims: Hepatocellular carcinoma (HCC) is the sixth most commonly occurring cancer worldwide. Knowledge and adherence to HCC surveillance guidelines has been associated with earlier detection. We sought to evaluate characteristics and outcomes following HCC diagnosis in patients screened for HCC in a large academic liver center versus patients diagnosed and referred from the community. Methods: We reviewed the records of patients diagnosed with HCC in the liver center of an academic institution from January 1999 till December 2013. Patients were classified into two groups: patients followed in our hepatology clinic and patients with HCC recently referred to our center. Univariate analysis was performed using chi-squared test and multivariate analysis was performed using SPSS 22.0. Results: The records of 410 patients were reviewed, and included 77.3% of patients referred from the community and 22.7% of patients followed in our clinic. In the clinic group, 75.6% were identified with one nodule at initial diagnosis, compared to 65.6% in the referral group. Patients in the referral group were more likely to present with tumors ≥5 cm at diagnosis, with 28.7% compared to 5.4% in the clinic group (p < 0.0001). Patients referred from the community were also less likely to undergo transplant, with 32.2% as compared to 48.4% of the clinic group (p < 0.004). Conclusion: Patients with chronic liver disease managed in an academic liver center present in the early stage of HCC diagnosis and are more likely to meet the Milan criteria and undergo transplant. Early referral to a specialized transplant center, if feasible, where a multidisciplinary approach is utilized might be essential in the management of chronic liver disease.

AB - Background and Aims: Hepatocellular carcinoma (HCC) is the sixth most commonly occurring cancer worldwide. Knowledge and adherence to HCC surveillance guidelines has been associated with earlier detection. We sought to evaluate characteristics and outcomes following HCC diagnosis in patients screened for HCC in a large academic liver center versus patients diagnosed and referred from the community. Methods: We reviewed the records of patients diagnosed with HCC in the liver center of an academic institution from January 1999 till December 2013. Patients were classified into two groups: patients followed in our hepatology clinic and patients with HCC recently referred to our center. Univariate analysis was performed using chi-squared test and multivariate analysis was performed using SPSS 22.0. Results: The records of 410 patients were reviewed, and included 77.3% of patients referred from the community and 22.7% of patients followed in our clinic. In the clinic group, 75.6% were identified with one nodule at initial diagnosis, compared to 65.6% in the referral group. Patients in the referral group were more likely to present with tumors ≥5 cm at diagnosis, with 28.7% compared to 5.4% in the clinic group (p < 0.0001). Patients referred from the community were also less likely to undergo transplant, with 32.2% as compared to 48.4% of the clinic group (p < 0.004). Conclusion: Patients with chronic liver disease managed in an academic liver center present in the early stage of HCC diagnosis and are more likely to meet the Milan criteria and undergo transplant. Early referral to a specialized transplant center, if feasible, where a multidisciplinary approach is utilized might be essential in the management of chronic liver disease.

KW - Hepatocellular carcinoma

KW - Liver transplant

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=85083095871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083095871&partnerID=8YFLogxK

U2 - 10.14218/JCTH.2016.00051

DO - 10.14218/JCTH.2016.00051

M3 - Article

SN - 2225-0719

VL - 5

SP - 31

EP - 34

JO - Journal of Clinical and Translational Hepatology

JF - Journal of Clinical and Translational Hepatology

IS - 1

ER -